Congressional Briefing: The Progress and Promise of Restorative Reproductive Medicine
Invitation to Congressional Briefing
Come learn more about the progress and promise of restorative reproductive medicine (RRM)— the holistic approach to infertility and reproductive health.
- Presentation from IIRRM Medical Leaders
- RRM Clinician and Patient Testimonials
- Q&A Panel
- Complimentary lunch provided
- RSVP is required to attend
Event Overview
With infertility rates climbing in the United States, medical experts from the International Institute for Restorative Reproductive Medicine (IIRRM) will highlight restorative reproductive medicine (RRM) as an important, cost-effective treatment option that benefits patients and public health. This growing medical discipline focuses on diagnosing and treating underlying causes of infertility, offering couples a path to natural conception by optimizing reproductive health.
Why This Matters
RRM represents an important option in reproductive healthcare and is part of the solution to America’s increasing infertility challenges. While IVF may be the only answer for a small subset of patients, most couples with infertility have underlying causes that are identifiable and treatable.
About the IIRRM
The International Institute for Restorative Reproductive Medicine is a medical society founded in London, UK, in 2000.The mission of the IIRRM is to unite medical professionals and researchers to promote and improve clinical practice, research, and education in RRM.The IIRRM currently represents medical professionals and researchers from 52 countries and maintains an academic journal (Journal of Restorative Reproductive Medicine), a clinician recognition program, and an international clinical practice registry (Surveillance of Treatment and Outcomes in Restorative Reproductive Medicine).
RRM Speakers Availability
The Congressional Briefing event will include Q&A, and the following IIRRM directors will be available for interviews in Washington D.C. September 15-16: Dr. Joseph Stanford (Director of Research), Dr. Tracey Parnell (Global Director of Communications & Development), and Dr. Monica Minjeur (U.S. Director of Communications & Development). Patients providing testimonials will also be available for in-person or virtual interviews.
Related Events
